NCT00006509View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2007

Conditions

HIV Infections

Interventions

BIOLOGICAL

ALVAC(2)120(B,MN)GNP (vCP1452)

BIOLOGICAL

gp160 MN/LAI-2

Trial Locations (1)

10016

Aaron Diamond AIDS Res Ctr, New York

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH